Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended

Recent studies demonstrate that early molecular response to tyrosine-kinase inhibitors is strongly predictive of outcome in chronic myeloid leukemia patients and that early response landmarks may identify patients at higher risk for transformation who would benefit from an early switch to second-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huet, Sarah, Cony-Makhoul, Pascale, Heiblig, Maël, Tigaud, Isabelle, Gazzo, Sophie, Belhabri, Amine, Souche, Denis, Michallet, Mauricette, Magaud, Jean-Pierre, Hayette, Sandrine, Nicolini, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159116/
https://www.ncbi.nlm.nih.gov/pubmed/25203717
http://dx.doi.org/10.1371/journal.pone.0106250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159116/
https://www.ncbi.nlm.nih.gov/pubmed/25203717
http://dx.doi.org/10.1371/journal.pone.0106250

Ejemplares similares